Show simple item record

dc.contributor.authorTunçay, Eylem
dc.contributor.authorGüngör, Gökay
dc.contributor.authorGüngör, Sinem
dc.contributor.authorSaltürk, Cüneyt
dc.contributor.authorAksoy, Emine
dc.contributor.authorÇiftaslan Gökşenoğlu, Nezihe
dc.contributor.authorIrmak, İlim
dc.contributor.authorAdıgüzel, Nalan
dc.date.accessioned2021-12-21T08:31:42Z
dc.date.available2021-12-21T08:31:42Z
dc.date.issued2019
dc.identifier.issn2587-0998
dc.identifier.issn2587-1404
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TXpRMU56VXpNdz09/antibiotherapy-and-mortality-rate-in-ventilator-associated-pneumonia-and-tracheobronchitis-due-to-acinetobacter-baumannii
dc.identifier.urihttps://doi.org/10.14744/scie.2019.58966
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/833
dc.description.abstractObjective: Ventilator-associated pneumonia (VAP) due to Acinetobacter baumannii (A. baumannii) has a high mortality rate in the intensive care unit (ICU). The guidelines recommendempirical antimicrobial therapy in cases of VAP; however, similar treatment
dc.description.abstractAmaç: Yoğun bakım ünitesinde (YBÜ) Acinetobacter baumanii’ye (A. baumanii) bağlı gelişen ventilatör ilişkili pnömonide (VİP) mortalite yüksektir. VİP’te ampirik antimikrobiyal tedavinin önemi rehberler tarafından vurgulanırken ventilatör ilişkili trakeob
dc.language.isoEnglish
dc.titleAntibiotherapy and Mortality Rate in Ventilator-Associated Pneumonia and Tracheobronchitis due to Acinetobacter Baumannii
dc.title.alternativeAcinetobacter baumanii’ye bağlı Trakeobronşit ve Pnömonide Antibiyoterapi ve Mortalite Oranı
dc.relation.journalSouthern Clinics of Istanbul Eurasia
dc.identifier.issue3
dc.identifier.startpage191
dc.identifier.endpage197
dc.identifier.volume30
dc.identifier.doi10.14744/scie.2019.58966
dc.relation.issue3
dc.relation.volume30


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record